Artikel ; Online: Amelioration of mild and moderate depression through Pranic Healing as adjuvant therapy: randomised double-blind controlled trial.
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
2017 Band 26, Heft 1, Seite(n) 82–87
Abstract: Objectives: Depression is a mental disorder, affecting the quality of life. Our study explores the efficacy of Pranic Healing (PH), as an adjuvant therapy in treating depression Methods: In this randomised double-blind controlled trial, 52 participants ... ...
Abstract | Objectives: Depression is a mental disorder, affecting the quality of life. Our study explores the efficacy of Pranic Healing (PH), as an adjuvant therapy in treating depression Methods: In this randomised double-blind controlled trial, 52 participants with a mean age of 34.4 years, with mild to moderate depression were assessed using the Hamilton Depression Rating (HAM-D) scale during the 5-week study. Both Medication + PH (MedPH) and Medication + Mock PH (MedMockPH) groups comprising 26 members received Pranic and mock healing lasting 20 minutes per session respectively once a week for 4 weeks, along with the antidepressant drug. Results: The average decrease in HAM-D score in MedPH was median 11 (Interquartile Range (IQR) 7-12) and was significantly higher compared with the MedMockPH group median 6.5 (IQR 3-9). At pre-assessment, both groups had 8 cases of mild and 18 cases of moderate depression. At post-assessment, HAM-D showed that the improvement in depression category was seen in 69.2% of participants in the MedMockPH group and 100% in MedPH group. Conclusions: These results give first the evidence that PH can aid as an adjuvant therapy for depressed people. |
---|---|
Mesh-Begriff(e) | Adult ; Citalopram/pharmacology ; Combined Modality Therapy ; Depression/drug therapy ; Depression/therapy ; Depressive Disorder/drug therapy ; Depressive Disorder/therapy ; Double-Blind Method ; Female ; Humans ; Male ; Medicine, Ayurvedic ; Middle Aged ; Mind-Body Therapies/methods ; Outcome Assessment (Health Care) ; Serotonin Uptake Inhibitors/administration & dosage ; Serotonin Uptake Inhibitors/pharmacology ; Severity of Illness Index |
Chemische Substanzen | Serotonin Uptake Inhibitors ; Citalopram (0DHU5B8D6V) |
Sprache | Englisch |
Erscheinungsdatum | 2017-08-24 |
Erscheinungsland | England |
Dokumenttyp | Journal Article ; Randomized Controlled Trial |
ZDB-ID | 2213198-X |
ISSN | 1440-1665 ; 1039-8562 |
ISSN (online) | 1440-1665 |
ISSN | 1039-8562 |
DOI | 10.1177/1039856217726449 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6220: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 581: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.